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OBJECTIVES We measured phospholipase C (PLC) activity in the cultured skin fibroblasts obtained from
patients with and without coronary spasm and examined its correlation with coronary artery
vasomotility.
BACKGROUND Coronary artery vasomotility is enhanced in coronary spastic angina (CSA), but no
information is available for the intracellular signaling. In spontaneously hypertensive rats,
PLC activity in the skin fibroblasts has been shown to be enhanced.
METHODS Skin fibroblasts obtained from 24 patients with CSA—14 with organic coronary artery
disease (CAD) and 12 control subjects—were cultured by the explant method. Activity of
PLC was determined by incubating the membrane fraction with 3H-phosphatidyl inositol
bisphosphate and by quantifying 3H-inositol trisphosphate. In patients with CSA and control
subjects, the relations between PLC activity and coronary artery basal tone and constrictor
response to intracoronary acetylcholine (ACh) were examined.
RESULTS Activity of PLC (pmol/protein [mg] per min) was 1.74 6 0.19 in patients with CSA; 0.90 6
0.12 in patients with CAD; and 0.65 6 0.07 in control subjects (p , 0.001, patients with
CSA vs. patients with CAD and control subjects; p 5 NS, patients with CAD vs. control
subjects). According to the Lineweaver-Burk plot, Michaelis constant (mmol/liter) of PLC
was 28 6 4 in patients with CSA; 49 6 14 in patients with CAD; and 56 6 10 in control
subjects (p , 0.05, patients with CSA vs. control subjects), whereas the maximal velocity was
not different between the three groups. There were significant positive correlations between
PLC activity and both basal tone (p 5 0.0108) and response to ACh (p 5 0.0053). Western
blot analysis using membrane fraction demonstrated that 89% of PLC isoenzymes detected
was of the d1 isoform.
CONCLUSIONS Because the PLC activity measured was genetically defined and was positively correlated with
coronary artery vasomotility, enhanced PLC activity may be involved in the pathogenesis of
coronary spasm. (J Am Coll Cardiol 2000;36:1847–52) © 2000 by the American College of
Cardiology
Coronary artery spasm plays an important role in the
pathogenesis of variant angina (1–3), as well as in other
acute coronary syndromes (4,5). We (6) and other investi-
gators (7,8) have shown that the basal tone of the entire
coronary artery system of Japanese patients with variant
angina is enhanced. Occlusive coronary artery constriction is
readily induced by diverse constrictor stimuli (9). These
suggest an impaired intracellular signaling in the process of
coronary artery smooth muscle contraction.
Phospholipase C (PLC) hydrolyzes phosphatidyl inositol
4,5-bisphosphate (PIP2) and produces inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol. The IP3 mobilizes
Ca21 from the intracellular stores and elicits rapid contrac-
tion of the smooth muscle cells (10). Diacylglycerol activates
protein kinase C (PKC) and initiates sustained contraction
(11). Using swine coronary spasm models, Ito et al. (12) and
Katsumata et al. (13) indicated that the PKC-mediated
pathway and enhanced myosin light chain phosphorylation
play an important role in the enhanced constrictor response
of the coronary artery smooth muscle. In contrast, PLC
activity has been shown to be enhanced not only in the
vascular smooth muscle cells (14), but also in the fibroblasts
obtained from the aortic adventitia (15) and skin (16) of
spontaneously hypertensive rats. This enhancement is
present while the rats are in the prehypertensive state (14).
The enhanced PLC activity in the fibroblasts may be linked
with that in the vascular smooth muscle cell, because these
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cells have similar characteristics as connective tissue cells
(17,18).
In clinical cases of variant angina, the incidences of both
migraine and Raynaud’s phenomenon were high as com-
pared with those in control subjects (19). Also, enhanced
esophageal motility in patients with variant angina has been
reported (20). These suggest a generalized disorder of
smooth muscle contraction and led us to test the hypothesis
that impaired intracellular signaling is present in these
patients. The present study was designed to examine PLC
activity in the cultured skin fibroblasts obtained from the
patients with coronary artery spasm and to compare it with
that in the patients without coronary spasm. Skin fibroblast
was used because it can be readily obtained and is suitable
for the experiments on cultured cells.
METHODS
Study patients. The study protocol was approved by our
Institution’s Ethics Committee. Written, informed consent
was obtained from all patients before the study. Fifty
patients in whom the skin fibroblast was successfully cul-
tured were included in the study. Group A consisted of 24
patients with coronary spastic angina (CSA) (Table 1) and
without significant stenotic coronary artery lesions. Ten of
the 24 patients had angiographically normal coronary arter-
ies, whereas the remaining 14 had mild (#50% lumen
diameter stenosis) atherosclerotic lesions. In 12 patients, ST
segment elevation was recorded on the electrocardiogram
(ECG) during a spontaneous or hyperventilation-induced
attack. Coronary spasm, defined as total occlusion or severe
vasoconstriction of the coronary artery associated with chest
pain and ischemic ECG changes, was induced with an
intracoronary injection of acetylcholine (ACh) in 20 pa-
tients. In the remaining four patients, all of whom had been
diagnosed with variant angina, induction of spasm was not
attempted. Group B consisted of 14 patients with signifi-
cant coronary artery disease (CAD). None had a clinical
history suggestive of CSA. Group C consisted of 12 control
subjects without angina pectoris and with normal coronary
arteries. These patients underwent cardiac catheterization
because of atypical chest pain (n 5 8) or cardiac arrhythmias
(n 5 4). Treadmill exercise and hyperventilation tests were
performed in the patients with atypical chest pain, and
neither anginal attack nor ST segment change was induced
in any of them. Intracoronary ACh was done in six of them,
and coronary spasm was not induced in any patients.
In all three groups, patients with hypertension (systolic
pressure $160 mm Hg or diastolic pressure $95 mm Hg)
or who had received medication for hypertension in the past
were excluded from the study, because hypertension itself
may affect PLC activity (14). In Groups A and C, all
medications except sublingual nitroglycerin were withdrawn
at least three days before the angiographic study.
Cardiac catheterization. The coronary arteriographic
study was performed while the patients were in the fasting
state. Eleven ECG leads, except aVR, and arterial pressure
were continuously monitored during catheterization. In 20
patients in Group A and six in Group C with atypical chest
pain, after baseline coronary arteriography, an intracoronary
injection of ACh (50 and 100 mg) was given (21). In two
patients in Group A, ACh was injected only in the right
coronary artery. When ACh-induced spasm did not resolve
spontaneously within 2 min or if hemodynamic instability
developed, isosorbide dinitrate (ISDN) was administered.
Coronary arteriograms were taken in multiple projections
after intracoronary ISDN (2.0 mg).
Quantitative coronary angiography and analysis of re-
sponse to ACh. Each of the three major coronary arteries
was divided into three or four segments, and the lumen
diameter of each segment was measured quantitatively
(Cardio 500, Kontron Electronik, Munich, Germany). In
Group A, the measurement was done at baseline, after
intracoronary ACh-induced coronary spasm and after
ISDN. In Group C, it was done at baseline, after intracoro-
nary ACh (100 mg for the left and 50 mg for the right
coronary artery) and after ISDN. The basal tone was
calculated as follows: 100 3 (diameter after ISDN 2
baseline diameter)/diameter after ISDN. The response to
ACh was calculated as follows: 100 3 (baseline diameter 2
diameter after ACh)/baseline diameter. Because the pa-
tients with coronary spasm have enhanced basal tone (6,8),
the response to ACh was normalized by the diameter after
Abbreviations and Acronyms
ACh 5 acetylcholine
CAD 5 coronary artery disease
CSA 5 coronary spastic angina
IP3 5 inositol 1,4,5-trisphosphate
ISDN 5 isosorbide dinitrate
Km 5 Michaelis constant
PIP2 5 phosphatidyl inositol 4,5-bisphosphate
PKC 5 protein kinase C
PLC 5 phospholipase C
Vmax 5 maximal velocity of reaction
Table 1. Clinical Profiles of the Study Patients
Group A
(n 5 24)
Group B
(n 5 14)
Group C
(n 5 12)
Sex (male/female) 19/5 11/3 6/6
Age (yr) 62 6 2 66 6 2 61 6 2
Smoking 16/24 (67%) 9/14 (64%) 6/12 (50%)
Systolic blood pressure
(mm Hg)
117 6 4 122 6 6 127 6 4
Diastolic blood pressure
(mm Hg)
71 6 2 71 6 3 77 6 4
Total cholesterol (mg/dl) 193 6 6 192 6 11 187 6 9
LDL cholesterol (mg/dl) 110 6 5 121 6 9 111 6 5
HDL cholesterol (mg/dl) 54 6 2 45 6 4 52 6 5
Triglyceride (mg/dl) 144 6 15 133 6 19 121 6 19
Blood sugar (mg/dl) 100 6 4 116 6 6* 101 6 3
BMI (kg/m2) 22.7 6 0.5 22.9 6 0.6 24.2 6 1.0
BMI 5 body mass index; HDL 5 high density lipoprotein; LDL 5 low density
lipoprotein. Values are mean 6 SEM. *p , 0.05 vs. Groups A and C.
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ISDN and calculated as follows: 100 3 (diameter after
ISDN 2 diameter after ACh)/diameter after ISDN. Both
the basal tone and response to ACh were calculated for all
coronary artery segments. The average basal tone and
maximal constrictor response and average response to ACh
were determined for each patient.
Culture of skin fibroblast. At the time of cardiac cathe-
terization, a small piece of skin was obtained from the
femoral region. Primary fibroblasts were cultured by the
explant method (22). Fibroblasts from the second to fourth
passages were used for the study. Our preliminary study
revealed that there was no difference in PLC activity
(pmol/protein [mg] per min) among fibroblasts obtained
from different regions (0.93 6 0.16 in the cervical and
0.92 6 0.17 in the femoral regions, n 5 6) and among
fibroblasts at different passages (0.87 6 0.20 at the second
and 0.93 6 0.19 at the fourth passages, n 5 4).
Membrane preparation. Confluent monolayers were
scraped and homogenized (23). The homogenate was cen-
trifuged at 500 g for 10 min, and the supernatant was
centrifuged at 40,000 g for 15 min. The pellet was stored at
280°C. The protein content was measured spectrophoto-
metrically.
Assay for membrane PLC activity. The PLC assay
system included the following components (24): N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid
(50 mmol/liter), CaCl2 (0.1 mmol/liter), sodium cholate
(9 mmol/liter), 3H-PIP2 (40,000 cpm) and membrane protein
(20 mg), in a final volume of 200 ml. Four assay systems were
incubated for 0, 2, 4 and 6 min at 37°C. The reaction was
stopped with chloroform/methanol/hydrogen chloride (HCl)
followed by 1N HCl containing EGTA. After extraction, the
aqueous phase was removed for liquid scintillation counting.
Production of 3H-IP3 was linear when the reaction time was
between 0 and 6 min and membrane protein was between 10
and 40 mg.
Michaelis constant (Km) and maximal velocity (Vmax) of
PLC. In 22 patients in Group A, 10 patients in Group B
and 9 patients in Group C, PLC activity was determined
under high concentrations of cold PIP2 (50, 25, 12.5 and
6.25 mmol/liter), and a Lineweaver-Burk plot was delin-
eated. The Km, which reflects the affinity of PLC for
substrate, with a low Km indicating high affinity, and Vmax,
which reflects the amount of the enzyme, were calculated
according to this plot.
Western blot analysis of PLC isoenzymes. Membrane
fraction obtained from four patients in Group A and four
patients in Group C was subjected to SDS-PAGE using a
gradient gel. Protein was transferred electrophoretically to a
nitrocellulose membrane. The membranes were then treated
with anti-PLC-b2 and b3 polyclonal antibodies (Santa
Cruz Biotechnology, Santa Cruz, California) and anti-
PLC-g and d1 monoclonal antibodies (Transduction Lab-
oratories, Lexington, Kentucky) and stained by amplified
alkaline phosphatase immunoblot kits.
Data analysis. All data are shown as the mean value 6
SEM. Comparison of continuous variables among the three
groups was performed with one-way analysis of variance
followed by the Fisher protected least significant difference
multiple comparisons test, and comparison of categoric
variables was done using the chi-square test. To examine
whether any of these variables had an effect on PLC activity,
univariate analysis was performed. The interaction between
the variables and PLC activity was examined by multiple
regression analysis. The relations between each of the
average basal coronary artery tone, maximal constrictor
response to ACh and average response to ACh and PLC
activity were examined with linear regression analysis. A p
value ,0.05 was considered statistically significant.
RESULTS
Clinical profiles of the patients. Table 1 shows the clinical
profiles and laboratory data of the study patients. There was
no statistical difference among the three groups, except for
fasting blood sugar level. When the variables were compared
between Group A and Groups B and C, none of them was
different between the groups.
Comparison of PLC activity, Km and Vmax. Figure 1
shows PLC activity for the three groups. Mean PLC activity
(pmol/protein [mg] per min) was 1.74 6 0.19 in Group A,
0.90 6 0.12 in Group B and 0.65 6 0.07 in Group C (p ,
0.001, Group A vs. Groups B and C; p 5 NS, Group B vs.
Group C). In Group A, there was no statistical difference in
the activity between the patients with angiographically
normal coronary arteries (1.81 6 0.23) and those with mild
coronary artery disease (1.57 6 0.34). Mean Km (mmol/
liter) in Groups A, B and C were 28 6 4, 49 6 14 and 56 6
11, respectively (p 5 0.023, Group A vs. C; p 5 0.0701,
Group A vs. B), whereas mean Vmax (pmol/protein [mg] per
min) were 941 6 182, 592 6 97 and 755 6 140,
respectively (p 5 NS, among the three groups).
Analysis of the effect of clinical profiles on PLC activity.
Univariate analysis showed that among the clinical variables
listed in Table 1, only age was correlated with PLC activity
(y 5 2.91 2 0.03x, R2 5 0.08, p 5 0.045). Multiple
Figure 1. Mean phospholipase C activity of the three groups. See text for
details.
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regression analysis, however, revealed that none of the
variables was significantly correlated with PLC activity.
Relationship of PLC activity with coronary artery vaso-
motility. BASAL TONE. The average coronary artery diam-
eter after ISDN was not different between Group A (2.8 6
0.1 mm) and Group C (2.7 6 0.1 mm). The average basal
tone was 26.8 6 3.3% in Group A and 19.7 6 3.0% in
Group C (p 5 NS). A significant positive correlation was
noted between the average basal coronary artery tone and
PLC activity (Fig. 2).
RESPONSE TO ACH (FIG. 3). The maximal constrictor re-
sponse to ACh was 82.3 6 3.6% in Group A and 39.2 6
3.1% in Group C (p , 0.0001). A significant positive
correlation was noted between the maximal constrictor
response to ACh and PLC activity (Fig. 3A) and between
that normalized by ISDN and PLC activity (Fig. 3B).
The average response to ACh was 45.0 6 2.0% in Group
A and 14.5 6 1.6% in Group C (p , 0.0001). A significant
positive correlation was noted between the average response
to ACh and PLC activity (Fig. 3C) and between that
normalized by ISDN and PLC activity (Fig. 3D).
Phospholipase C isoenzymes in membrane fraction of
skin fibroblast. Western blot analysis demonstrated that
88.7 6 3.4% of PLC isoenzymes detected was of the d1
isoform and the other small fraction b3. Figure 4 shows
PLC-d1 consisting of 70- and 85-kd bands for two patients
in Group A (lanes 3 and 4) and two patients in Group C
(lanes 1 and 2). The ratio of these bands to bovine serum
albumin as a molecular standard was not different between
Group A (0.66 6 0.12, n 5 4) and Group C (0.69 6 0.09,
n 5 4).
DISCUSSION
A diffuse vasomotion abnormality in all of the epicardial
coronary arteries has been suggested to be involved in the
pathogenesis of coronary spasm, at least in Japanese patients
(6–8,25). Maseri et al. (26), however, described that the
cause and significance of the generalized increase in coro-
nary vasomotility seen in some patients with variant angina
differ from those of segmental occlusive spasm, and they
Figure 2. Relationship between the average basal coronary artery tone and
PLC activity. Open circles 5 control subjects without coronary spasm;
solid circles 5 patients with CSA. See text for details.
Figure 3. Relations between the maximal constrictor response to ACh from the baseline diameter and PLC activity (A), between the maximal constrictor
response normalized by ISDN and PLC activity (B), between the average response to ACh from the baseline diameter and PLC activity (C) and between
the average response normalized by ISDN and PLC activity (D). Open circles 5 control subjects without coronary spasm; solid circles 5 patients with
CSA. See text for details.
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recently pointed out the racial differences in the coronary
vasomotor reactivity between Japanese and white patients
(27).
The endothelium-dependent vasodilation to ACh was
shown to be impaired during the atherosclerotic process
(28). A diffuse vasomotion abnormality in CSA, however,
cannot be explained solely by the atherosclerotic process that
causes a “paradoxic” vasoconstriction to ACh (29). Recently,
Nakayama et al. (30) reported that the T27863 C mutation
in the endothelial nitric oxide synthase gene reduces nitric
oxide synthesis and may predispose the patients with this
mutation to coronary spasm. However, all of the patients do
not necessarily have this gene mutation.
Enhanced PLC activity in patients with coronary spasm.
The initial intracellular signaling for vascular smooth muscle
contraction involves hydrolysis of PIP2 in the plasma
membrane with activated PLC, and the resultant produc-
tion of IP3 and diacylglycerol. In spontaneously hyperten-
sive rats, PLC activity has been shown to be enhanced not
only in the vascular smooth muscle cells (14), but also in the
fibroblasts obtained from the aortic adventitia (15) and skin
(16). The enhanced PLC activity, genetically defined, may
possibly induce pathologic changes in the blood vessels and
may cause physiologic disorders in the regulation of sys-
temic and regional circulation.
The present study demonstrated that PLC activity in the
skin fibroblast was enhanced in patients with CSA. Our
preliminary study showed that the stimulation of the mem-
brane fraction of cultured skin fibroblasts with arginine-
vasopressin or angiotensin II did not affect PLC activity.
Thus, the enhanced PLC activity is suggested to be due to
the impairment of PLC itself or its regulatory mechanism.
This study further revealed that Km, a concentration of
substrate at which half of Vmax was obtained, was signifi-
cantly smaller in the group of patients with CSA than in the
other groups, whereas Vmax was not different between the
patients with and without coronary spasm. This suggests
that the enhanced PLC activity was not due to a quantita-
tive impairment, but rather to a qualitative impairment.
Although patients with hypertension were excluded, the
blood pressure in the patients with enhanced PLC activity
(Group A) was not high as compared with that in the
patients with lower activity (Groups B and C). Also, there
was no significant correlation between PLC activity and blood
pressure. Enhanced PLC activity, as shown in this study, may
not be linked with the pathogenesis of hypertension.
At present, there have been 10 PLC isoenzymes identi-
fied, excluding alternatively spliced forms (31). Four isoen-
zymes of PLC-b, two of PLC-g and four of PLC-d have
been reported. The present Western blot analysis demon-
strated that a major PLC isoenzyme detected in the mem-
brane fraction of skin fibroblast was of the d1 isoform, and
there was no difference in the amount between Groups A
and C. It was recently reported that the missense mutation
in the PH domain of the human PLC-d1 gene was
associated with a remarkable loss of function (32). Further
studies on the mechanisms of enhanced PLC-d1 activity in
the patients with CSA should be required.
Relationship between PLC activity and coronary vaso-
motility. The constrictor response to ACh of the coronary
arteries of the patients with CSA was enhanced, as com-
pared with that of the patients without spastic angina. In
contrast, the basal coronary artery tone in the patients with
coronary spasm was not increased, which is inconsistent
with the findings of our previous report (6). The coronary
angiographic study in the previous study was performed in
the early morning, whereas that in the present study was not
necessarily done in the morning.
To clarify the relationship between PLC activity deter-
mined in the skin fibroblast and coronary artery vasomotil-
ity, we examined how PLC activity was correlated with the
coronary artery basal tone and vasomotor response to ACh.
It was clearly shown that PLC activity was correlated
significantly with not only basal coronary artery tone, but
also the maximal constrictor and average responses of the
coronary artery to ACh. Thus, higher PLC activity corre-
sponded with greater basal tone and constrictor response to
ACh. This correlation of PLC activity with coronary artery
vasomotility may suggest the role of enhanced PLC activity
in the genesis of coronary spasm.
Study limitations and implications. The major limitation
of this study was the lack of evidence that PLC activities of
the skin fibroblast and coronary artery smooth muscle cell
are closely correlated with each other. It is almost impossible
to obtain the coronary artery smooth muscle cell from
patients with CSA. Furthermore, at present, it is impossible
to estimate PLC activity of the coronary artery smooth
muscle in situ. We used cultured fibroblast, and the PLC
activity that was determined was most likely to be geneti-
cally defined. The correlation between measured PLC
activity and coronary artery vasomotility determined in vivo
may be indirect evidence for the role of enhanced PLC in
the genesis of coronary spasm; further studies are required.
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